Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KL130008 in Severe Alopecia Areata
NCT05496426Phase 2Terminated
- Sponsor
- Kelun-Biotech
- Start
- Nov 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KL130008 in alopecia areata, sponsored by Kelun-Biotech. Started Nov 2022; status: terminated.
02
Drugs
KL130008
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05496426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05496426.